Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts

Sotera Health Company (NASDAQ:SHC) has received a consensus rating of “Moderate Buy” from the eleven brokerages that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $20.4286.

A number of research analysts recently issued reports on the company. Royal Bank Of Canada initiated coverage on Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 target price for the company. Citigroup increased their price target on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. William Blair began coverage on Sotera Health in a research note on Thursday, December 18th. They issued an “outperform” rating for the company. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Finally, BMO Capital Markets started coverage on shares of Sotera Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price on the stock.

Sotera Health Price Performance

Sotera Health stock opened at $14.66 on Monday. The firm has a market cap of $4.17 billion, a PE ratio of 54.30 and a beta of 1.84. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. The company’s 50 day moving average is $17.73 and its two-hundred day moving average is $16.84.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The business had revenue of $303.44 million during the quarter, compared to the consensus estimate of $300.68 million. During the same quarter in the previous year, the firm posted $0.21 earnings per share. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, research analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Institutional Investors Weigh In On Sotera Health

A number of large investors have recently modified their holdings of the company. Empowered Funds LLC lifted its stake in Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after purchasing an additional 43,471 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock worth $293,000 after purchasing an additional 14,018 shares in the last quarter. Teacher Retirement System of Texas lifted its position in shares of Sotera Health by 4.1% during the 2nd quarter. Teacher Retirement System of Texas now owns 23,707 shares of the company’s stock worth $264,000 after buying an additional 933 shares during the last quarter. Finally, Vise Technologies Inc. purchased a new stake in shares of Sotera Health during the 2nd quarter worth approximately $148,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.